Submitted by Etelvina Domingos (etelvina.domingos@ufpe.br) on 2015-03-12T17:33:14Z No. of bitstreams: 2 DISSERTAÇÃO Arnaldo César Dantas dos Santos Andrade.pdf: 7831380 bytes, checksum: 66d5438c268c796c6cdb3d1cd4e40f5a (MD5) license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) / Made available in DSpace on 2015-03-12T17:33:14Z (GMT). No. of bitstreams: 2 DISSERTAÇÃO Arnaldo César Dantas dos Santos Andrade.pdf: 7831380 bytes, checksum: 66d5438c268c796c6cdb3d1cd4e40f5a (MD5) license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Previous issue date: 2013 / Um dispositivo eletrônico para teste laboratorial remoto ou point-of-care testing (POCT) foi desenvolvido para detecção de glicose, sendo três as suas unidades estruturais: a fonte de luz, o sensor plasmônico e o transdutor de sinal. Após testes na primeira unidade estrutural do instrumento, optou-se por fonte de luz do tipo laser de ondas contínuas, trabalhando no comprimento de onda 780 nm. A segunda unidade estrutural é resultante de técnicas de engenharia molecular e síntese coloidal de um sensor plasmônico, estável, consumível em única dose. Funcionalizou-se a superfície dos nanobastões de ouro (NBAu), revestindo-os com polieletrólitos e em seguida conjugou-se com enzima glicose oxidase (GO) em camadas, pelo método layer-by-layer (LBL). As camadas foram caracterizadas por espectroscopia UVVis- NIR e obteve-se uma relação qualitativa entre estas e seus respectivos espectros de ressonância localizada de plasmon de superfície (LSPR). A LSPR possibilita uma ampla variedade de aplicações em dispositivos sensores baseados neste fenômeno. Os NBAu sintetizados neste trabalho apresentaram dois modos de absorção: (i) 550 nm o qual corresponde ao modo de oscilação transversal e (ii) 744 nm para o modo de oscilação longitudinal e sua morfologia foi obtida por microscopia eletrônica de transmissão (MET). Foi possível investigar a estabilidade de nanobastões funcionalizados com concentrações de poliestirenosulfonato de sódio (PSS). O sensor plasmônico NBAu-PSS-Poliacrilamida(PAM)- GO distinguiu absorções para soluções de concentrações distintas de glicose. Para a terceira unidade estrutural do instrumento foram selecionados transdutores de sinal e desenvolveu-se uma abordagem experimental que permitiu defini-los e programá-los a fim de reproduzir respostas correspondentes àquelas de analisadores convencionais. Um analisador de modulações LSPR foi programado no dispositivo eletrônico e ocorreu em conjunto com a síntese das nanoestruturas. A especificação do emissor de luz, a construção do sensor NBAu- PSS-PAM-GO e a definição do transdutor de sinal, permitiram elaborar uma instrumentação prática para a diagnóstico rápido. Este trabalho veio reforçar a importância da aplicação de nanoestruturas anisotrópicas para reconhecimento de macromoléculas. Uma estratégia semelhante foi contemplada neste mesmo dispositivo eletrônico, demonstrada em anticorpos conjugados aos nanobastões para reconhecimento da proteína troponina, como prova de conceito.

Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / The key research question examined in this thesis was: Could POCT ( point-of-care pathology testing) models that were analytically sound and clinically and culturally effective be established in Australian Indigenous medical services for the prevention and management of diabetes and renal disease? The systematic approach to answer this overarching research question included the scientific validation of the analytical performance of suitable point-of-care (POC) devices, the development of a culturally appropriate education and training program for Aboriginal Health Workers (and nurses) as POCT operators, the implementation of a quality management framework for maintaining surveillance of the analytical quality of POCT results, and an assessment of qualitative and quantitative research outcomes to determine the clinical and cultural effectiveness of POCT. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1277656 / Thesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice, 2007

Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / The key research question examined in this thesis was: Could POCT ( point-of-care pathology testing) models that were analytically sound and clinically and culturally effective be established in Australian Indigenous medical services for the prevention and management of diabetes and renal disease? The systematic approach to answer this overarching research question included the scientific validation of the analytical performance of suitable point-of-care (POC) devices, the development of a culturally appropriate education and training program for Aboriginal Health Workers (and nurses) as POCT operators, the implementation of a quality management framework for maintaining surveillance of the analytical quality of POCT results, and an assessment of qualitative and quantitative research outcomes to determine the clinical and cultural effectiveness of POCT. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1277656 / Thesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice, 2007

Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / The key research question examined in this thesis was: Could POCT ( point-of-care pathology testing) models that were analytically sound and clinically and culturally effective be established in Australian Indigenous medical services for the prevention and management of diabetes and renal disease? The systematic approach to answer this overarching research question included the scientific validation of the analytical performance of suitable point-of-care (POC) devices, the development of a culturally appropriate education and training program for Aboriginal Health Workers (and nurses) as POCT operators, the implementation of a quality management framework for maintaining surveillance of the analytical quality of POCT results, and an assessment of qualitative and quantitative research outcomes to determine the clinical and cultural effectiveness of POCT. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1277656 / Thesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice, 2007

A biosensor is an analytical device integrating a biological element and a physicochemical transducer that convert a biological response into a measurable signal. The advantages of biosensors include low cost, small size, quick, sensitivity and selectivity greater than the conventional instruments. Biosensors have a wide range of applications ranging from clinical diagnostics through to environmental monitoring, agriculture industry, et al. The different types of biosensors are classified based on the sensor device as well as the biological material. Biosensors can be broadly classified into (piezoelectric, etc.), electrochemical biosensors (potentiometric, amperometric, etc.), and optical types of biosensors (fiber optics, etc.). Here, we introduce a novel microfluidics-integrated biosensor platform system that can be flexibly adapted to form individual biosensors for different applications. In this dissertation, we present five examples of different emerging areas with this biosensor system including anti-cancer drug screening, glucose monitoring, heavy metal elements measurement, obesity healthcare, and waterborne pathogen DNA detection. These micro-biosensors have great potential to be further developed to emerging portable sensing devices especially for the uses in the developing and undeveloped world. At the last chapter, Raman spectroscopy applied to assess gestational status and the potential for pregnancy complications is presented and discussed. This technique could significantly benefit animal reproduction.

No description available.

L’évaluation externe de la qualité (EEQ) est un outil indispensable qui permet au laboratoire d’analyse de biologie clinique de surveiller la qualité de ses analyses. Une analyse rétrospective sur 391 893 résultats appartenant à sept analytes fréquemment dosés (glucose, calcium, triglycérides, créatine kinase, hémoglobine, HbA1c et protéines urinaires) a été réalisée sur une période de douze ans, de 1996 à 2007. Pour trois analytes, les résultats accumulés par trois Centres européens suisse, français et belge organisant des EEQ ont été comparés. Une approche statistique simple non paramétrique a été utilisée afin de calculer les performances (CV % et pourcentages de résultats conformes interlaboratoires) en incluant tous les résultats des EEQ, y compris les valeurs aberrantes. Le travail a permis de calculer les performances des appareils en fonction des analytes, de comparer les performances entre les Centres et entre deux types d’utilisateurs – les laboratoires professionnels et les cabinets médicaux – et, enfin, de calculer l’évolution des performances dans le temps. Il en ressort que les performances entre les Centres sont comparables et les appareils des laboratoires professionnels obtiennent de meilleures performances par rapport aux petits analyseurs utilisés dans les cabinets médicaux.Concernant les POCT, les performances ne dépendent pas du type d’utilisateur mais du type de POCT : certains obtiennent des performances comparables aux appareils de laboratoire, d’autres inférieures. Globalement, une amélioration des performances est mesurée pour les deux types d’utilisateurs, pour la plupart des appareils et pour tous les analytes. / The external quality assessment (EQA) is an essential tool that allows medical laboratories to supervise the quality of their analyses. A retrospective analysis on 391.893 results originating from seven frequently measured analytes (glucose, calcium, triglycerides, creatine kinase, haemoglobin, HbA1c, and urinary proteins) was performed over a twelveyear period, from 1996 to 2007. For three analytes, the results accumulated by three European Centres – Swiss, French, and Belgian – organising EQA surveys were compared. A simple non-parametrical statistical approach was used to calculate the performances (inter-laboratory CV% and percentage of correct results) in order to include all EQA results, even aberrant values. The work allowed to calculate the performances of devices for the different analytes, to compare performances among the Centres and among two types of users – professional laboratories and medical offices – and, finally to calculate the evolution of performances over time. It turns out that performances among the Centres are comparable and that professional laboratory devices obtained better performances as compared with small laboratory devices used in medical offices. Concerning POCT devices, performances are not linked to the type of user but to the POCT type : certain types reach the same performances as laboratory devices, while others are below. A general improvement of performances is measured for both types of users, for most devices, and for all the analytes.

<p>Objectives: To evaluate the long term total imprecision of HbA1c testing within the county of Uppsala in relation to the Swedish analytical goal of coefficient of variation (CV) <3% for HbA1c and to study the cost of an external quality assurance program for point-of-care HbA1c The county uses Bayer DCA 2000™ for point-of care HbA1c testing currently having 23 of these instruments.</p><p>Methods: Method imprecision was assessed by analysis of patient samples performed as split samples during a 3 year period (2002-2004) as part of the quality assurance program for point-of-care HbA1c testing. The samples were first analysed on a Bayer DCA 2000™ and the samples were then sent to the centralised laboratory for reanalysis with an HPLC system (Variant II™, Biorad). The testing was performed approximately 8 times per year with each instrument.</p><p>Results: The median CV between the HPLC method and the point-of-care instruments for each unit was slightly higher than 3%.</p><p>Conclusion: The DCA 2000™ systems have an acceptable imprecision and agreement with the central laboratory. The test results show acceptable agreements within the county regardless where the patient is tested. The cost of the external quality assurance program is calculated to be approximately SEK 1340 (Euro 150) per instrument.</p>

Objectives: To evaluate the long term total imprecision of HbA1c testing within the county of Uppsala in relation to the Swedish analytical goal of coefficient of variation (CV) &lt;3% for HbA1c and to study the cost of an external quality assurance program for point-of-care HbA1c The county uses Bayer DCA 2000™ for point-of care HbA1c testing currently having 23 of these instruments. Methods: Method imprecision was assessed by analysis of patient samples performed as split samples during a 3 year period (2002-2004) as part of the quality assurance program for point-of-care HbA1c testing. The samples were first analysed on a Bayer DCA 2000™ and the samples were then sent to the centralised laboratory for reanalysis with an HPLC system (Variant II™, Biorad). The testing was performed approximately 8 times per year with each instrument. Results: The median CV between the HPLC method and the point-of-care instruments for each unit was slightly higher than 3%. Conclusion: The DCA 2000™ systems have an acceptable imprecision and agreement with the central laboratory. The test results show acceptable agreements within the county regardless where the patient is tested. The cost of the external quality assurance program is calculated to be approximately SEK 1340 (Euro 150) per instrument.

L'évaluation externe de la qualité (EEQ) est un outil indispensable qui permet au laboratoire d'analyse de biologie clinique de surveiller la qualité de ses analyses. Une analyse rétrospective sur 391 893 résultats appartenant à sept analytes fréquemment dosés (glucose, calcium, triglycérides, créatine kinase, hémoglobine, HbA1c et protéines urinaires) a été réalisée sur une période de douze ans, de 1996 à 2007. Pour trois analytes, les résultats accumulés par trois Centres européens suisse, français et belge organisant des EEQ ont été comparés. Une approche statistique simple non paramétrique a été utilisée afin de calculer les performances (CV % et pourcentages de résultats conformes interlaboratoires) en incluant tous les résultats des EEQ, y compris les valeurs aberrantes. Le travail a permis de calculer les performances des appareils en fonction des analytes, de comparer les performances entre les Centres et entre deux types d'utilisateurs - les laboratoires professionnels et les cabinets médicaux - et, enfin, de calculer l'évolution des performances dans le temps. Il en ressort que les performances entre les Centres sont comparables et les appareils des laboratoires professionnels obtiennent de meilleures performances par rapport aux petits analyseurs utilisés dans les cabinets médicaux.Concernant les POCT, les performances ne dépendent pas du type d'utilisateur mais du type de POCT : certains obtiennent des performances comparables aux appareils de laboratoire, d'autres inférieures. Globalement, une amélioration des performances est mesurée pour les deux types d'utilisateurs, pour la plupart des appareils et pour tous les analytes.